Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA

Background Randomized trials of pharmacologic strength omega‐3 fatty acid (n3‐FA)–based therapies suggest a dose‐dependent cardiovascular benefit. Whether blood n3‐FA levels also mediate safety signals observed in these trials, such as increased bleeding and atrial fibrillation (AF), remains uncerta...

Descripció completa

Dades bibliogràfiques

Autors principals:	Karan Kapoor, Abdulhamied Alfaddagh, Mahmoud Al Rifai, Deepak L. Bhatt, Matthew J. Budoff, Khurram Nasir, Michael Miller, Francine K. Welty, J. William McEvoy, Zeina Dardari, Michael D. Shapiro, Roger S. Blumenthal, Michael Y. Tsai, Michael J. Blaha
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-06-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	arrhythmia atrial fibrillation bleeding docosahexaenoic acid eicosapentaenoic acid omega‐3
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.121.021431
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!